Endonovo Therapeutics Correlations
| ENDV Stock | USD 0.0007 0.0001 12.50% |
The current 90-days correlation between Endonovo Therapeutics and Bio Path Holdings is -0.01 (i.e., Good diversification). The correlation of Endonovo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Endonovo Therapeutics Correlation With Market
Good diversification
The correlation between Endonovo Therapeutics and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Endonovo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Endonovo |
The ability to find closely correlated positions to Endonovo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Endonovo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Endonovo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Endonovo Therapeutics to buy it.
Moving together with Endonovo Pink Sheet
| 0.68 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.66 | BKRKY | Bank Rakyat | PairCorr |
| 0.61 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.64 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Endonovo Pink Sheet
| 0.76 | SSNLF | Samsung Electronics | PairCorr |
| 0.73 | HD | Home Depot | PairCorr |
| 0.71 | PTAIF | PT Astra International | PairCorr |
| 0.67 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.67 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
| 0.66 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.65 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.65 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.65 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.64 | WMT | Walmart Aggressive Push | PairCorr |
| 0.62 | XOM | Exxon Mobil Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.53 | HPQ | HP Inc | PairCorr |
| 0.51 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.39 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.35 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Endonovo Pink Sheet performing well and Endonovo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Endonovo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BPTH | 3.79 | (0.14) | 0.00 | 0.75 | 0.00 | 6.67 | 51.22 | |||
| CING | 4.90 | (0.76) | 0.00 | (0.88) | 0.00 | 9.27 | 38.00 | |||
| PPBT | 5.42 | (1.04) | 0.00 | 1.24 | 0.00 | 8.53 | 32.62 | |||
| SLNO | 2.18 | 0.07 | 0.03 | 0.19 | 2.50 | 5.87 | 13.40 | |||
| GNLX | 4.66 | 0.60 | 0.09 | 1.30 | 5.06 | 13.94 | 40.11 | |||
| CMRA | 5.99 | 0.12 | 0.00 | 0.01 | 0.00 | 13.95 | 30.28 | |||
| DYAI | 3.88 | 0.45 | 0.08 | 1.78 | 3.98 | 9.00 | 31.56 | |||
| MNPR | 20.43 | 10.98 | 0.92 | (2.33) | 7.87 | 15.93 | 653.56 | |||
| CMVLF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Endonovo Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |